Immediate Impact
66 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
2024 Standout
Works of Ahmet Sezer being referenced
378MO EMPOWER-Lung 1: Phase III first-line (1L) cemiplimab monotherapy vs platinum-doublet chemotherapy (chemo) in advanced non-small cell lung cancer (NSCLC) with programmed cell death-ligand 1 (PD-L1) ≥50%
2020
Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Ahmet Sezer | 226 | 162 | 73 | 44 | 388 | |
| Taher Abu Hejleh | 246 | 151 | 64 | 44 | 423 | |
| Yael Flamand | 139 | 106 | 78 | 36 | 401 | |
| Jairam Krishnamurthy | 230 | 114 | 65 | 34 | 410 | |
| Birsen Yücel | 198 | 120 | 60 | 49 | 349 | |
| Y.S. Chae | 185 | 118 | 50 | 41 | 396 | |
| Süheyla Serdengeçti | 159 | 94 | 99 | 42 | 436 | |
| Chi Wha Han | 135 | 84 | 67 | 39 | 380 | |
| Emilie Bogart | 104 | 234 | 102 | 35 | 418 | |
| Anne-Birgitte Jacobsen | 179 | 140 | 194 | 29 | 443 | |
| Azusa Tokue | 186 | 132 | 67 | 39 | 422 |
All Works
Login with ORCID to disown or claim papers
Loading papers...